LIVE ONLINE Conference Programme




07 Nov 2021

(Timings are in Greenwich Mean Time - add session to your diary using link below)

Benefits of homeopathic complementary treatment in breast cancer patients. A retrospective cohort

Introduction: There is a growing use of complementary therapy in oncology and homeopathy features prominently. Their purpose is to help patients better cope with the illness and the side effects (SEs) of cancer treatments that particularly affect quality of life (HRQOL). However, there are few comparative studies. The objective of this study is to assess the benefits of homeopathy treatment on the HRQOL for patients with non-metastatic breast cancer (BC), prescribed in post-surgical complementary therapy, compared to treatment without homeopathy.

Keywords: homeopathy, breast cancer, complementary therapy, HRQOL


Dr. Jacques MEDIONI - Oncologist - Georges Pompidou European Hospital
Dr. Yecenia LOPEZ MARQUEZ - Homeopathic general practitioner - Private practice
Dr. Daniel SCIMECA - Homeopathic general practitioner - Private practice
Mrs Emmanuelle LERAY - Teacher-researcher, epidemiologist - EHESP School of Public Health
Mrs Marie DALICHAMPT - Biostatistician, epidemiologist, healthcare data expert - ORS Pays de la Loire

Dr Mohammed Bennani, CEO of a CRO, Qualees - France

The joint congress for ESIM and ISCMR:

Organised in association with:

Gold Sponsors:


Silver Sponsors:


Supported by: